|
1 Company |
|
1 Product |
|
1 Product |
|
1 Mechanism of Action |
|
0 Trials |
|
11 News |
|
- | Trial completion: Short-term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome (clinicaltrials.gov) - Dec 22, 2015
P2, N=13, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting --> Completed
- Trial withdrawal: A Long-Term Study of Cholesterol Supplements for Smith-Lemli-Opitz Syndrome (clinicaltrials.gov) - Oct 22, 2014
P=N/A, N=0, Withdrawn, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting --> Completed Completed --> Withdrawn
- | simvastatin / Generic mfg.
Trial completion: Simvastatin Therapy in Smith-Lemli-Opitz Syndrome (clinicaltrials.gov) - Jun 4, 2014
P2, N=23, Completed, Sponsor: Forbes Porter, M.D.
Completed --> Withdrawn Active, not recruiting --> Completed
- | Trial completion: Prenatal Screening For Smith-Lemli-Opitz Syndrome (clinicaltrials.gov) - Feb 22, 2014
P2, N=1800, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment change: A Long-Term Study of Cholesterol Supplements for Smith-Lemli-Opitz Syndrome (clinicaltrials.gov) - Dec 11, 2013
P=N/A, N=8, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting --> Completed N=25 --> 8
- Trial completion: A Long-Term Study of Cholesterol Supplements for Smith-Lemli-Opitz Syndrome (clinicaltrials.gov) - Dec 11, 2013
P=N/A, N=8, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
N=25 --> 8 Recruiting --> Completed
- Trial completion: Cholesterol in ASD: Characterization and Treatment (clinicaltrials.gov) - Nov 14, 2013
P1/2, N=44, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change: Cholesterol in ASD: Characterization and Treatment (clinicaltrials.gov) - Mar 26, 2013
P1/2, N=44, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Active, not recruiting --> Completed N=900 --> 44
- lovastatin / Generic mfg.
Trial withdrawal: Novel Treatment for Syndromic Ichthyoses (clinicaltrials.gov) - Nov 28, 2012
P2, N=0, Withdrawn, Sponsor: Northwestern University
N=900 --> 44 Not yet recruiting --> Withdrawn
- lovastatin / Generic mfg.
Enrollment change: Novel Treatment for Syndromic Ichthyoses (clinicaltrials.gov) - Nov 28, 2012
P2, N=0, Withdrawn, Sponsor: Northwestern University
Not yet recruiting --> Withdrawn N=15 --> 0